First Quarter 2018 Investor Presentation

Investor Presentation First three months of 2018 Slide 22 Novo Nordisk strategic foundation STRATEGIC PRIORITIES Strengthen leadership in DIABETES CARE CORE CAPABILITIES Engineering, formulating, developing and delivering protein-based treatments Deep disease understanding Strengthen leadership in OBESITY CARE Pursue leadership in HAEMOPHILIA Strengthen leadership in GROWTH DISORDERS Expand into other SERIOUS CHRONIC DISEASES changing diabetes Novo Nordisk Way Efficient large-scale production of proteins Global commercial reach and leader in chronic disease care Driving change to defeat diabetes and other serious chronic conditions novo nordisk

View entire presentation